Tripos, Inc., a leading provider of drug discovery
chemistry and informatics products and services, today announced that Tripos Discovery
Research Ltd. (TDR), based in Bude, England, has formed a new research collaboration
with Cara Therapeutics, an emerging U.S. biotechnology company based in Tarrytown,
N.Y. Cara is focused on developing novel therapeutics to treat medical conditions
associated with pain and inflammation. Terms of the agreement were not disclosed.